Authors: LASSFLORL C KOFLER G KROPSHOFER G HERMANS J KRECZY A DIERICH MP NIEDERWIESER D

Citation: C. Lassflorl et al., IN-VITRO TESTING OF SUSCEPTIBILITY TO AMPHOTERICIN-B IS A RELIABLE PREDICTOR OF CLINICAL OUTCOME IN INVASIVE ASPERGILLOSIS, Journal of antimicrobial chemotherapy, 42(4), 1998, pp. 497-502

Authors: NACHBAUR D FINK FM NUSSBAUMER W GACHTER A KROPSHOFER G LUDESCHER C NIEDERWIESER D

Citation: D. Nachbaur et al., CD34(-SELECTED AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT) IN PATIENTS WITH POOR-RISK HEMATOLOGICAL MALIGNANCIES AND SOLID TUMORS - A SINGLE-CENTER EXPERIENCE()), Bone marrow transplantation, 20(10), 1997, pp. 827-834

Authors: NACHBAUR D DUBA HC FEICHTINGER H KROPSHOFER G NUSSBAUMER W SCHWAIGHOFER H NIEDERWIESER D

Citation: D. Nachbaur et al., POLYCHEMOTHERAPY COMBINED WITH G-CSF-MOBILIZED DONOR BUFFY COAT TRANSFUSION FOR GRANULOCYTIC SARCOMA AFTER ALLOGENEIC BMT FOR AML, Bone marrow transplantation, 19(9), 1997, pp. 947-949

Authors: NACHBAUR D KROPSHOFER G FEICHTINGER H ALLERBERGER F NIEDERWIESER D

Citation: D. Nachbaur et al., CRYPTOSPORIDIOSIS AFTER CD34-SELECTED AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT) - TREATMENT WITH PAROMOMYCIN, AZITHROMYCIN AND RECOMBINANT HUMAN INTERLEUKIN-2, Bone marrow transplantation, 19(12), 1997, pp. 1261-1263

Authors: SCHWAIGHOFER H OBERHUBER G HEBART H EINSELE H HEROLD M NACHBAUR D EIBL B TILG H KROPSHOFER G FERRARA JLM NIEDERWIESER D

Citation: H. Schwaighofer et al., ENDOGENOUS INTERLEUKIN-1 RECEPTOR ANTAGONIST DURING HUMAN BONE-MARROWTRANSPLANTATION - INCREASED LEVELS DURING GRAFT-VERSUS-HOST DISEASE, DURING INFECTIOUS COMPLICATIONS, AND AFTER IMMUNOGLOBULIN THERAPY, Transplantation, 63(1), 1997, pp. 52-56